Could hibernating squirrels open new doors to novel obesity treatments? The new partnership between Eli Lilly and Fauna Bio plans to find out. (Endpoints News)
A total of 51 members from 18 countries joined together on an expert panel to draft a consensus statement aimed at tackling diabetes stigma and discrimination. (Lancet Diabetes & Endocrinology)
Following an October recall of some hemodialysis machines for potential toxic compounds, the FDA sent Fresenius Medical Care a warning letter outlining a slew of violations this week.
Patients who initially thought they would be good candidates for SGLT-2 inhibitors are turning to older drugs used for weight loss. (CNN)
For every extra 1 cm of waist circumference, a 3% increase in infertility risk was observed among U.S. women, researchers reported in PLOS One.
The New York State Department of Health is looking into Bellevue Hospital’s use of unlicensed technicians to assist doctors in bariatric surgeries following a New York Times investigation suggesting the Manhattan hospital performed a high volume of procedures on vulnerable individuals.
Hua Medicine submitted an investigational new drug application to the FDA looking to start a phase I trial for its second-generation glucokinase allosteric activator for type 2 diabetes.
Endocrinology had the second highest share of telehealth spending, making up 9% of Medicare claims data from 2022, according to an American Medical Association report.
Topical corticosteroids at any dose were linked with elevated risks of osteoporosis and bone fractures over a 5-year follow-up period. (Journal of the European Academy of Dermatology and Venereology)
Check out the case of a 49-year-old woman with thyroid dermopathy in Graves’ disease. (New England Journal of Medicine)
More and more patients are pairing anti-obesity drugs with bariatric surgery. (Axios)
Please enable JavaScript to view the